In this episode, moderator Bethany Moore will join David Vaillencourt, CEO of The GMP Collective, Jini Glaros of Modern Canna Labs, andd Dylan Wilks of Orange Photonics.
In this webinar, we explore intoxicating hemp and synthetic cannabinoids have permeated the cannabis market, but there are not many regulatory requirements for production and product testing.
Gain valuable insights into how embracing ESG principles and fostering DEI initiatives can contribute to a more sustainable, socially responsible, and inclusive cannabis sector.
The GMP Collective kicked off 2024 with a fresh webinar episode of When Things Go Wrong by dissecting the nuances between hemp-derived and synthetic cannabinoids including THCa, THCP, Delta-8, Delta-9, and more.
In this episode, we delved into lab testing issues in the cannabis industry, including lab shopping and THC inflation. We highlighted the need for a new perspective on flower potency testing and the importance of representative sampling. We also discussed the misconceptions about THC content and quality, and the complexities of CRM shopping, measurement uncertainty, and shelf stability.
Every day in the industry, we see companies making common mistakes when it comes to how cannabis facilities are designed. Consider a dispensary that inadvertently sells moldy or contaminated products–as a result of poor planning and facility design, this GMP crisis not only compromises consumer safety, but can cost companies hundreds of thousands of dollars to clean up.
The hot topic of social venues designed solely for cannabis consumption is one that raises as many questions as it does high anticipation, not only for consumers but cannabusinesses as well. Social consumption lounges, when done mindfully, could be a serious game changer for the cannabis industry
We are thrilled to announce the Cannabis Compliance Alliance (CCA) and The GMP Collective’s own David Vaillencourt are now on YouTube!
In this episode, moderator Bethany Moore will join David Vaillencourt, CEO of The GMP Collective, Jini Glaros of Modern Canna Labs, andd Dylan Wilks of Orange Photonics.
In this webinar, we explore intoxicating hemp and synthetic cannabinoids have permeated the cannabis market, but there are not many regulatory requirements for production and product testing.
Gain valuable insights into how embracing ESG principles and fostering DEI initiatives can contribute to a more sustainable, socially responsible, and inclusive cannabis sector.
The GMP Collective kicked off 2024 with a fresh webinar episode of When Things Go Wrong by dissecting the nuances between hemp-derived and synthetic cannabinoids including THCa, THCP, Delta-8, Delta-9, and more.
In this episode, we delved into lab testing issues in the cannabis industry, including lab shopping and THC inflation. We highlighted the need for a new perspective on flower potency testing and the importance of representative sampling. We also discussed the misconceptions about THC content and quality, and the complexities of CRM shopping, measurement uncertainty, and shelf stability.
Every day in the industry, we see companies making common mistakes when it comes to how cannabis facilities are designed. Consider a dispensary that inadvertently sells moldy or contaminated products–as a result of poor planning and facility design, this GMP crisis not only compromises consumer safety, but can cost companies hundreds of thousands of dollars to clean up.
The hot topic of social venues designed solely for cannabis consumption is one that raises as many questions as it does high anticipation, not only for consumers but cannabusinesses as well. Social consumption lounges, when done mindfully, could be a serious game changer for the cannabis industry
We are thrilled to announce the Cannabis Compliance Alliance (CCA) and The GMP Collective’s own David Vaillencourt are now on YouTube!